<- Back to digest

JOT - 2026-11-01 - Journal Article; Comparative Study

Ballistic Forearm Fractures are Associated with Higher Neurovascular Injury, Nonunion, and Complications Compared With Blunt Forearm Injuries.

Barber HF, Pereira DE, Rust BD, Perugini JM, Reaver CN, Guissé NF, Wilson JL, Obey MR, McAndrew CM, Berkes MB

retrospective cohortLOE IIIn = 395 patients, 398 fractures (81 ballistic, 213 blunt-closed, 104 blunt-open)Not reported (2018–2023 study period at single institution)

Topics

trauma
PMID: 42407994DOI: 10.1097/BOT.0000000000003242View on PubMed ->

Key Takeaway

Ballistic forearm fractures carry a 48.2% nerve deficit rate and 18.0% nonunion rate, significantly exceeding blunt-closed injuries (6.3% and 5.6%, respectively), with ballistic mechanism remaining an independent predictor of nerve deficit, complication, and unplanned reoperation on multivariable analysis.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This retrospective cohort compared outcomes of operatively managed diaphyseal forearm fractures stratified by mechanism—ballistic, blunt-closed, and blunt-open—at a single Level 1 trauma center. Ballistic fractures demonstrated significantly higher nerve deficit (48.2% vs. 6.3%), overall complication (38.5% vs. 21.1%), and unplanned reoperation rates (30.8% vs. 14.2%) versus all blunt injuries combined. Nonunion was elevated in ballistic versus blunt-closed fractures (18.0% vs. 5.6%) but did not reach significance versus blunt-open fractures (18.0% vs. 9.2%), and infection rates were similar across groups.

Key Limitation

Minimum follow-up duration is not defined, meaning nonunion and nerve recovery rates may be underestimated if patients were lost to follow-up before 9-month radiographic endpoints.

Original Abstract

OBJECTIVES

To characterize injury patterns, treatment differences, and clinical outcomes associated with ballistic and blunt forearm fractures.

DESIGN

Retrospective cohort study.

SETTING

Single Level 1 tertiary trauma center, 2018-2023.

PATIENT SELECTION CRITERIA

The study included adults (≥18) who underwent operative fixation of diaphyseal radius and/or ulna fractures. Exclusion criteria were ipsilateral intraarticular or unstable elbow injuries, pathologic fractures, or fractures involving preexisting implants. Patients were stratified into 2 groups: ballistic and blunt injuries, which were further subclassified as blunt-closed or blunt-open.

OUTCOME MEASURES AND COMPARISONS

Primary outcomes included nerve deficit, complication rate, unplanned reoperation, nonunion, and postoperative infection.

RESULTS

The study included 395 patients with 398 forearm fractures: 81 ballistic fractures in 78 patients [32 years (18-69), 88.9% male], 213 blunt-closed fractures [41 years (18-82), 59.2% male], and 104 blunt-open fractures [46 years (19-92), 71.2% male]. Ballistic fractures had significantly higher rates of nerve deficits (48.2% vs. 6.3%, P < 0.001), complications (38.5% vs. 21.1%, P = 0.020), and unplanned reoperation (30.8% vs. 14.2%, P = 0.012) compared with blunt injuries. Infection rates were similar between ballistic and blunt groups (10.3% vs. 5.8%, P = 0.294). Nonunion differed only between ballistic and blunt-closed fractures (18.0% vs. 5.6%, P = 0.042), not blunt-open fractures (18.0% vs. 9.2%, P = 0.228). On multivariable analysis, injury group remained an independent predictor of nerve deficit ( P < 0.001), complication ( P = 0.008), and unplanned reoperation ( P = 0.015), with ballistic injuries demonstrating the highest rates.

CONCLUSIONS

Ballistic forearm fractures posed unique challenges compared with blunt injuries. They were associated with significantly higher rates of nerve deficit, unplanned reoperations, and overall complications, with higher nonunion observed when compared with blunt-closed injuries. These injuries warrant a high index of suspicion for nerve injury and close long-term follow-up to optimize patient outcomes and address the needs of a disproportionately affected, high-risk population.

LEVEL OF EVIDENCE

Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.